Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN51287398
ISRCTN51287398
Completed
Not Applicable

Randomised multicentre clinical trial: endovenous laser treatment of the great saphenous vein using a bare fibre versus tulip fibre

Sint-Andriesziekenhuis vzw (Belgium)0 sites300 target enrollmentApril 6, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsVaricose disease, endovenous laser treatment.Circulatory SystemVaricose veins of lower extremities

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Varicose disease, endovenous laser treatment.
Sponsor
Sint-Andriesziekenhuis vzw (Belgium)
Enrollment
300
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 6, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sint-Andriesziekenhuis vzw (Belgium)

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with insufficiency of the great saphenous vein with functional and/or aesthetical inconvenience
  • •2\. 1470/1500 nm endovenous laser treatment
  • •3\. Aged between 18 \- 80 years
  • •4\. Male or female

Exclusion Criteria

  • •1\. Deep venous insufficiency
  • •2\. Cross\-dilatation with more than two incompetent side\-branches
  • •3\. Maximal diameter of the saphenous vein greater than 15 mm
  • •4\. Therapeutical anticoagumlation or hypocoagulopathy
  • •5\. Hypercoagulopathy/thrombophilia
  • •6\. Peripheral arterial occlusive disease: Ankle\-Brachial Index (ABI) less than 0\.85 or history of claudication or ischaemia
  • •7\. Pregnancy
  • •8\. Patients younger than 18 years and older than 80 years
  • •9\. Bilateral treatment
  • •10\. Insufficiency of the small and/or anterior saphenous vein

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Multicenter Randomized CLinical trial of endovascular treatment for acute ischemic stroke in the Netherlands. The effect of periprocedural MEDication: heparin, antiplatelet agents, both or neither.Brain infarctionIschemic Stroke100079631000318410014523
NL-OMON53150Erasmus MC, Universitair Medisch Centrum Rotterdam1,500
Recruiting
Phase 3
Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in The Netherlands for Late Arrivals: MR CLEAN LATEbrain infarctionischemic stroke1000796310014523
NL-OMON55450Medisch Universitair Ziekenhuis Maastricht500
Active, not recruiting
Phase 1
Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both or neitherAcute ischemic strokeMedDRA version: 21.1Level: LLTClassification code 10055221Term: Ischemic strokeSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2017-001466-21-FRErasmus MC University Medical Center1,500
Active, not recruiting
Phase 1
Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands. The effect of periprocedural MEDication: heparin, antiplatelet agents, both or neither.
EUCTR2017-001466-21-NLErasmus MC University Medical Center1,500
Completed
Phase 4
Multi-centre Prospective Randomized Trial Intravenous Itraconazole versus Liposomal Amphotericin B For Empirical Antifungal Therapy In Patients With Persistent fever And Neutropenia (ILEAN study)
JPRN-UMIN000005529ational Hospital Organization850